Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc News Story

$5.95 0.0  0.0%

Last Trade - 06/11/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.9m
Position in Universe th / 6715

BRIEF-Dimension Therapeutics says on termination of merger with Ultragenyx co will be required to pay Ultragenyx a termination fee of $2.9 mln-SEC filing

Tue 3rd October, 2017 1:44pm
Oct 3 (Reuters) - Dimension Therapeutics Inc  DMTX.O : 
    * Dimension Therapeutics says on termination of merger with 
Ultragenyx co will be required to pay Ultragenyx a termination 
fee of $2.9 million-SEC filing 
    * Dimension Therapeutics-co to reimburse Ultragenyx for $2.9 
million fee paid by Ultragenyx on behalf of dimension for 
termination of Regenxbio deal 
 
Source text: (http://bit.ly/2xZwnrr) 
Further company coverage:  DMTX.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.